LRRK2 and Parkinson disease: LRRK2 G2019S mutation elevates mobility of α-synuclein and enhances α-synuclein accumulation in cultured primary neurons and in dopaminergic neurons in SNc of PD brain (Volpicelli-Daley et al., 2016).